domingo, 18 de agosto de 2024

Azithromycin therapy for prevention of chronic lung disease of prematurity (AZTEC): a multicentre, double-blind, randomised, placebo-controlled trial

https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(24)00079-1/fulltext?dgcid=hubspot_update_feature_updatealerts_lanres&utm_campaign=update-lanres&utm_medium=email&_hsenc=p2ANqtz-9IU-2K4i6fGTAdoHTyBpF-ArPcjuMMjzxegXBNjMeBHue4BX-a1lk4bbNM8MXEctWUsvZZQnHpGNRCUIuXeiLwEouG3A&_hsmi=319737070&utm_content=319691243&utm_source=hs_email

No hay comentarios:

Publicar un comentario